Funding for this research was provided by:
Japan Agency for Medical Research and Development (16cm0106513h0001)
MEXT | Japan Society for the Promotion of Science (JP16H05308)
Research grants from Boehringer-Ingelheim, Eisai, and MSD, and Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University.
Received: 26 December 2019
Accepted: 24 August 2020
First Online: 14 September 2020
: Y.T. obtained honoraria from Chugai Pharma, AstraZeneca, and Boehringer-Ingelheim. T. Yamada obtained research grants from Ono Pharma, Chugai Pharma, Pfizer Co, and Takeda Pharma. K. Kaira obtained research grants from AstraZeneca, and honoraria from Ono Pharma, Eli Lilly, Chugai Pharma, AstraZeneca, and Boehringer-Ingelheim. S.A. obtained grants and personal fees from Chugai, grants and non-financial support from F. Hoffmann-La Roche, grants and personal fees from Boehringer Ingelheim, grants and personal fees from AstraZeneca. S.Y. obtained research grants and honoraria from Chugai Pharma, AstraZeneca, and Boehringer-Ingelheim. The other authors have no conflict of interest.